# Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

> **NCT03933813** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 9 (actual)

## Conditions studied

- Epithelial Ovarian Cancer
- Anemia
- Iron Deficiency Anemia

## Interventions

- **OTHER:** Iron Sucrose

## Key facts

- **NCT ID:** NCT03933813
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-29
- **Primary completion:** 2021-11-22
- **Final completion:** 2021-11-22
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2023-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933813, "Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03933813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*